Predilife (France) Performance

ALPRE Stock  EUR 4.36  0.08  1.87%   
The company holds a Beta of 0.31, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Predilife's returns are expected to increase less than the market. However, during the bear market, the loss of holding Predilife is expected to be smaller as well. At this point, Predilife has a negative expected return of -0.15%. Please make sure to check Predilife's jensen alpha, accumulation distribution, relative strength index, as well as the relationship between the value at risk and day typical price , to decide if Predilife performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Predilife has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors. ...more
Begin Period Cash Flow3.1 M
Total Cashflows From Investing Activities-10.6 K
  

Predilife Relative Risk vs. Return Landscape

If you would invest  494.00  in Predilife on August 30, 2024 and sell it today you would lose (58.00) from holding Predilife or give up 11.74% of portfolio value over 90 days. Predilife is generating negative expected returns and assumes 3.061% volatility on return distribution over the 90 days horizon. Simply put, 27% of stocks are less volatile than Predilife, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Predilife is expected to under-perform the market. In addition to that, the company is 3.94 times more volatile than its market benchmark. It trades about -0.05 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of volatility.

Predilife Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Predilife's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Predilife, and traders can use it to determine the average amount a Predilife's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0482

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsALPRE

Estimated Market Risk

 3.06
  actual daily
27
73% of assets are more volatile

Expected Return

 -0.15
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.05
  actual daily
0
Most of other assets perform better
Based on monthly moving average Predilife is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Predilife by adding Predilife to a well-diversified portfolio.

Predilife Fundamentals Growth

Predilife Stock prices reflect investors' perceptions of the future prospects and financial health of Predilife, and Predilife fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Predilife Stock performance.

About Predilife Performance

Assessing Predilife's fundamental ratios provides investors with valuable insights into Predilife's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Predilife is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Predilife S.A. develops and sells medical techniques and mathematical models. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France. PREDILIFE is traded on Paris Stock Exchange in France.

Things to note about Predilife performance evaluation

Checking the ongoing alerts about Predilife for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Predilife help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Predilife generated a negative expected return over the last 90 days
Predilife has high historical volatility and very poor performance
Predilife has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 195.9 K. Net Loss for the year was (3.41 M) with loss before overhead, payroll, taxes, and interest of (3.52 M).
Predilife has accumulated about 94.9 K in cash with (3.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.93.
Evaluating Predilife's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Predilife's stock performance include:
  • Analyzing Predilife's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Predilife's stock is overvalued or undervalued compared to its peers.
  • Examining Predilife's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Predilife's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Predilife's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Predilife's stock. These opinions can provide insight into Predilife's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Predilife's stock performance is not an exact science, and many factors can impact Predilife's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Predilife Stock Analysis

When running Predilife's price analysis, check to measure Predilife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predilife is operating at the current time. Most of Predilife's value examination focuses on studying past and present price action to predict the probability of Predilife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predilife's price. Additionally, you may evaluate how the addition of Predilife to your portfolios can decrease your overall portfolio volatility.